{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:57:38Z","timestamp":1788893858860,"version":"build-2803163510"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Abiomed"},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013814","name":"Klinisk Institut, Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013814","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region of Southern Denmark"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Vasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in AMICS patients stratified according to the Society of Cardiovascular Angiography and Interventions (SCAI) shock classification.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>Retrospective analysis of patients with AMICS admitted to cardiac intensive care unit at two tertiary cardiac centers during 2010\u20132017 with retrieval of real-time hemodynamic data and dosages of vasoactive drugs from intensive care unit databases.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>Out of 1,249 AMICS patients classified into SCAI class C, D, and E, mortality increased for each shock stage from 34% to 60%, and 82% (p&lt;0.001). Treatment targets of mean arterial blood pressure &gt; 65mmHg and venous oxygen saturation &gt; 55% were reached in the majority of patients; however, more patients in SCAI class D and E had values below treatment targets within 24 hours (p&lt;0.001) despite higher vasoactive load and increased use of epinephrine for each severity stage (p&lt;0.001). In univariate analysis no significant difference in mortality within SCAI class D and E regarding vasoactive strategy was observed, however in SCAI class C, epinephrine was associated with higher mortality and a significantly higher vasoactive load to reach treatment targets. In multivariate analysis there was no statistically association between individually vasoactive choice within each SCAI class and 30-day mortality.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>Hemodynamic treatment targets were achieved in most patients at the expense of increased vasoactive load and more frequent use of epinephrine for each shock severity stage. Mortality was high regardless of vasoactive strategy; only in SCAI class C, epinephrine was associated with a significantly higher mortality, but the signal was not significant in adjusted analysis.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0272279","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T17:44:30Z","timestamp":1659635070000},"page":"e0272279","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1542-3260","authenticated-orcid":true,"given":"Nanna Louise Junker","family":"Udesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Kristian Lerche","family":"Helgestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Josiassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-0981","authenticated-orcid":true,"given":"Christian","family":"Hassager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Frederiksen","family":"H\u00f8jgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kjaergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Holmvang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-2429","authenticated-orcid":true,"given":"Lisette Okkels","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Berg","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Eifer","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"issue":"11","key":"pone.0272279.ref001","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ejhf.1566","article-title":"Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study","volume":"21","author":"OKL Helgestad","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"pone.0272279.ref002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","article-title":"Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States","volume":"107","author":"M Shah","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"pone.0272279.ref003","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock","volume":"341","author":"JS Hochman","year":"1999","journal-title":"N Engl J Med"},{"issue":"32","key":"pone.0272279.ref004","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: An update 2019","volume":"40","author":"H Thiele","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"pone.0272279.ref005","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1186\/cc10584","article-title":"Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry","volume":"15","author":"J Spinar","year":"2011","journal-title":"Crit Care"},{"issue":"1","key":"pone.0272279.ref006","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"Current real-life use of vasopressors and inotropes in cardiogenic shock\u2014adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"T Tarvasm\u00e4ki","year":"2016","journal-title":"Crit Care"},{"issue":"2","key":"pone.0272279.ref007","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"B Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"36","key":"pone.0272279.ref008","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"TA McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"pone.0272279.ref009","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of Dopamine and Norepinephrine in the Treatment of Shock Daniel","volume":"362","author":"Daniel De Backer","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0272279.ref010","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"JA Myburgh","year":"2008","journal-title":"Intensive Care Med"},{"issue":"2","key":"pone.0272279.ref011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction","volume":"72","author":"B Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"43","key":"pone.0272279.ref012","doi-asserted-by":"crossref","first-page":"e8402","DOI":"10.1097\/MD.0000000000008402","article-title":"Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis","volume":"96","author":"Q Rui","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"pone.0272279.ref013","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock","volume":"385","author":"R Mathew","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0272279.ref014","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients","volume":"44","author":"V L\u00e9opold","year":"2018","journal-title":"Intensive Care Med"},{"issue":"4","key":"pone.0272279.ref015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjcard.2019.05.039","article-title":"Predictors of Mortality and Outcomes of Acute Severe Cardiogenic Shock Treated with the Impella Device","volume":"124","author":"CL Rohm","year":"2019","journal-title":"Am J Cardiol"},{"issue":"1","key":"pone.0272279.ref016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"DA Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"pone.0272279.ref017","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association","volume":"79","author":"SS Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"pone.0272279.ref018","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gheart.2018.08.004","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"13","author":"K Thygesen","year":"2018","journal-title":"Glob Heart"},{"issue":"4","key":"pone.0272279.ref019","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bja.2018.12.019","article-title":"Vasoactive-inotropic score and the prediction of morbidity and mortality after cardiac surgery","volume":"122","author":"T Koponen","year":"2019","journal-title":"Br J Anaesth"},{"issue":"1","key":"pone.0272279.ref020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13054-019-2605-4","article-title":"Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: A single-center experience","volume":"23","author":"V Zotzmann","year":"2019","journal-title":"Crit Care"},{"issue":"3","key":"pone.0272279.ref021","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0300-9572(02)00266-6","article-title":"Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support","volume":"55","author":"W Schreiber","year":"2002","journal-title":"Resuscitation"},{"issue":"4","key":"pone.0272279.ref022","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/SHK.0000000000001390","article-title":"Temporal Trends and Clinical Outcomes Associated with Vasopressor and Inotrope Use in the Cardiac Intensive Care Unit","volume":"53","author":"JC Jentzer","year":"2020","journal-title":"Shock"},{"issue":"4","key":"pone.0272279.ref023","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/SHK.0b013e318167378f","article-title":"Increased aerobic glycolysis through \u03b22 stimulation is a common mechanism involved in lactate formation during shock states","volume":"30","author":"B Levy","year":"2008","journal-title":"Shock"},{"issue":"16","key":"pone.0272279.ref024","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary Management of Cardiogenic Shock: A Scientific Statement from the American Heart Association","volume":"136","author":"S Van Diepen","year":"2017","journal-title":"Circulation"},{"issue":"17","key":"pone.0272279.ref025","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE randomized trial","volume":"297","author":"A Mebazaa","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"pone.0272279.ref026","doi-asserted-by":"crossref","first-page":"e71659","DOI":"10.1371\/journal.pone.0071659","article-title":"The Effectiveness of Inodilators in Reducing Short Term Mortality among Patient with Severe Cardiogenic Shock: A Propensity-Based Analysis","volume":"8","author":"R Pirracchio","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"pone.0272279.ref027","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study","volume":"39","author":"B Levy","year":"2011","journal-title":"Crit Care Med"},{"issue":"1","key":"pone.0272279.ref028","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13054-020-2816-8","article-title":"Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock","volume":"24","author":"NLJ Udesen","year":"2020","journal-title":"Crit Care"},{"issue":"17","key":"pone.0272279.ref029","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit","volume":"74","author":"JC Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"pone.0272279.ref030","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1002\/ccd.28707","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock","volume":"96","author":"B Schrage","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"pone.0272279.ref031","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/ccd.29139","article-title":"SCAI shock classification in acute myocardial infarction: Insights from the National Cardiogenic Shock Initiative","volume":"96","author":"ID Hanson","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"pone.0272279.ref032","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)","volume":"37","author":"F Follath","year":"2011","journal-title":"Intensive Care Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T09:27:10Z","timestamp":1700904430000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272279"}},"subtitle":[],"editor":[{"given":"Gaetano","family":"Santulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0272279","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]}}}